Neuburgh Advisers’s HealthEquity HQY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
$2.56M Buy
44,752
+10,992
+33% +$730K 0.08% 190
2019
Q2
$2.21M Buy
33,760
+2,160
+7% +$150K 0.07% 210
2019
Q1
$2.34M Buy
31,600
+1,664
+6% +$117K 0.08% 194
2018
Q4
$1.79M Sell
29,936
-736
-2% -$59.3K 0.07% 206
2018
Q3
$2.9M Buy
30,672
+3,888
+15% +$335K 0.09% 182
2018
Q2
$2.01M Sell
26,784
-272
-1% -$19.5K 0.07% 214
2018
Q1
$1.64M Sell
27,056
-3,088
-10% -$167K 0.06% 210
2017
Q4
$1.41M Sell
30,144
-2,928
-9% -$145K 0.05% 240
2017
Q3
$1.67M Buy
33,072
+5,024
+18% +$234K 0.06% 204
2017
Q2
$1.4M Sell
28,048
-3,920
-12% -$183K 0.05% 223
2017
Q1
$1.36M Buy
31,968
+112
+0.4% +$4.96K 0.05% 231
2016
Q4
$1.29M Buy
+31,856
New +$1.23M 0.06% 207

Other funds holding HQY

Neuburgh Advisers's HQY Position: Q3 2019 in Review

Neuburgh Advisers increased its HealthEquity (HQY) stake by 33% in Q3 2019, buying an estimated $730K and bringing the position to 44,752 shares worth $2.56M. The position accounts for 0.08% of the portfolio, ranked #190.

Neuburgh Advisers first reported a position in HQY in Q4 2016 and has held it in 12 quarters since. The position peaked at $2.9M in Q3 2018. 303 funds tracked by Wall St. Rank hold HQY as of Q3 2019.

  • Neuburgh Advisers held 44,752 shares of HealthEquity worth $2.56M as of Q3 2019.
  • Neuburgh Advisers bought 10,992 HealthEquity shares in Q3 2019, an estimated $730K.
  • HealthEquity made up 0.08% of Neuburgh Advisers's portfolio in Q3 2019, its #190 holding.
  • Neuburgh Advisers first reported a position in HealthEquity in Q4 2016 and has held it in 12 quarters since.
  • Neuburgh Advisers's HealthEquity position peaked at $2.9M in Q3 2018.
  • 303 funds tracked by Wall St. Rank held HealthEquity as of Q3 2019.

Based on Neuburgh Advisers's 13F filing for Q3 2019, filed 14 Nov 2019.